PhD

Dr. Huang earned his Ph.D. in bioengineering from University of Pennsylvania and is currently a Senior Scientist in the Department of Ophthalmology and Visual Sciences at University of Wisconsin-Madison. He is co-director of the Fundus Photograph Reading Center, UW-Madison and co-founder and Chief Technology Officer for EyeKor. Dr. Huang has 15 years experience in developing software and hardware imaging solutions for ophthalmic imaging applications both in academic and industrial environments. Dr.

Dr. Danilov is Senior Scientist in the Orthopedics and Rehabilitation Medicine Department, University of Wisconsin School of Medicine and Public Health. He is a neuroscientist with over 30 years experience in research on brain function and the special senses, including vision, taste, and balance. His primary interest areas include neuroplasticity, neurorehabilitation, and sensory systems physiology. Dr.

Dr. Nickells is Professor and Vice Chair of Research in the Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison. He has appointments in the Department of Physiology, UW Comprehensive Cancer Center, Institute on Aging, and the Eye Research Institute. His research utilizes the tools of molecular biology to investigate pathophysiologic processes of the retina and optic nerve. His current research focuses on intracellular signaling pathways in glaucoma and neuroprotective mechanisms.

Dr. Levin is a visual scientist and neuro-ophthalmologist at the University of Wisconsin School of Medicine and Public Health and the University of Montreal. He specializes in diseases of the optic nerve, and studies optic neuropathies and retinal ganglion cell death at the molecular, biochemical, and cellular level. He serves as a consultant to pharmaceutical companies in the areas of neuroprotection and its application to human disease, including glaucoma.

Dr. Hartigan-O'Connor is an Assistant Professor of Medicine at the University of California, Davis. His research is focused on mechanisms of tolerance and immune privilege, both in the adult eye and in the developing fetus. His most recent work focuses on resilience of retinal immune privilege to inflammatory insults and neovascularization, as well as the potential of immunosuppressive drugs to maintain privilege despite these challenges. His work has been published in leading journals including Science Translational Medicine and the Journal of Experimental Medicine.

Dr. Eells is Associate Professor of Pharmacology and Toxicology at the University of Wisconsin-Milwaukee. She is widely recognized as an expert in neurotoxicology and the mechanisms of retinal and optic nerve toxicity, and has served as an advisor and consultant to pharmaceutical companies, government agencies, and the World Health Organization. She has in-depth knowledge of physiology, pharmacology, neurobiology and toxicology with particular expertise in ocular toxicology.

Dr. Polans is Associate Professor of Ophthalmology and Visual Sciences and Associate Professor of Biomolecular Chemistry at the University of Wisconsin-Madison. He is an expert in the biochemistry and molecular biology of the eye. His research program encompasses diverse fields of investigation including ocular tumors (especially melanoma), the remote effects of cancer in the eye as well as fundamental issues related to phototransduction.

Dr. Ver Hoeve is Senior Scientist and Director of Electrodiagnostic Services in the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health. He is responsible for electroretinographic and visual evoked potential testing in human patients and has conducted research in numerous animal models. He is currently investigating neuroprotection strategies in a non-human primate model of experimental glaucoma.

Dr. Reid is a Professor in the Departments of Ophthalmology and Vision Science and Biochemistry and Cell Biology at Texas Tech University. He has extensive experience as a biochemist and cell biologist in investigating the modulation of cell growth and wound healing processes. Recently, he has undertaken investigations concerning the structure/function relationships of neuropeptides as they relate to a variety of physiological functions.

Dr. Mutti is the E.F. Wildermuth Foundation Professor of Optometry at The Ohio State University College of Optometry. His research career began in the contact lens industry with CooperVision Ophthalmic Products where he evaluated lens design and product performance during in-house clinical trials. Dr. Mutti's current research interests are in the emmetropization of infants and the development of myopia in children. He was a co-investigator on the NEI-funded Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) study. Dr.